Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S329-329
- https://doi.org/10.1016/s0959-8049(99)81740-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: